Related Experiment Video
Updated: Apr 20, 2026
09:11
Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
Published on: February 13, 2016
10.5K
Hydrogel Nanoparticles with Thermally Controlled Drug Release
Teppei Shirakura1, Taylor J Kelson1, Aniruddha Ray1
1Biophysics and Chemistry, The University of Michigan , 930 North University Avenue, Ann Arbor, Michigan 48109, United States.
ACS Macro Letters
|November 25, 2014
Summary
This study introduces temperature-sensitive cisplatin-loaded nanoparticles (CisPt-NPs) for chemotherapy. These nanoparticles enhance drug release and efficacy at slightly elevated temperatures, offering a promising approach for targeted cancer treatment.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Chemotherapy faces challenges in therapeutic efficacy and systemic side effects.
- Targeted drug delivery systems are crucial for improving cancer treatment outcomes.
Purpose of the Study:
- To develop and evaluate temperature-sensitive hydrogel nanoparticles loaded with cisplatin (CisPt-NPs) for targeted chemotherapy.
- To investigate the stimuli-responsive drug release and in vitro efficacy of CisPt-NPs.
Main Methods:
- Synthesis of cisplatin-loaded, temperature-sensitive hydrogel nanoparticles (CisPt-NPs).
- Characterization of CisPt-NP drug release at varying temperatures and pH (neutral and lysosomal).
- In vitro assessment of CisPt-NP uptake, localization, and cytotoxicity in breast cancer cells (MDA-MB-435).
Main Results:
- CisPt-NPs demonstrated a temperature-dependent increase in cisplatin release at neutral and low pH.
- The nanoparticles were effectively endocytosed by MDA-MB-435 cells and localized in lysosomes.
- In vitro cytotoxicity tests showed significantly enhanced efficacy of CisPt-NPs at slightly elevated temperatures.
Conclusions:
- Temperature-sensitive CisPt-NPs offer a viable strategy for stimuli-responsive chemotherapy.
- These nanoparticles show potential for improved therapeutic efficacy and reduced side effects in cancer treatment.
- Further investigation into potential applications in targeted cancer therapy is warranted.
More Related Videos
Related Concept Videos
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
153
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
153
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
109
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
109
01:23Modified-Release Drug Delivery Systems: Classification
291
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
291
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
155
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
155
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
138
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
138
01:11Oral Drug Delivery Systems: Delayed-Release Systems
187
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
187